JSCPF yields 1.74% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, JSCPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JSCPF + JNJ for your $10,000?
JSR Corporation engages in the plastics, digital solutions, and life sciences businesses in Japan and internationally. Its Digital Solutions Business provides photoresists and multilayer materials, CMP materials, mounting materials, materials for color LCDs, functional coating materials, heat-resistant transparent resins and functional films, photo fabrication and photo molding systems, etc. for use in semiconductor devices, smartphones, LCD TVs, OLED panel materials, and other materials. The company's Life Sciences Business offers diagnostic and research reagents to purify antibodies and drugs; bio-process materials; drug discovery and development services for biopharmaceutical development process, etc. Its Plastics Business provides synthetic resins, including ABS, AES, AS, and ASA resins for use in automobile parts, household appliances, and building materials. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
Full JSCPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.